Progesterone: What This Lab Test Actually Measures

What Progesterone Is and Why It Matters

Progesterone is a steroid hormone belonging to the progestogen class. The ovaries produce the majority of circulating progesterone in premenopausal women, specifically from the corpus luteum, the temporary endocrine structure that forms after an egg is released during ovulation. Smaller amounts come from the adrenal glands in both sexes and from the testes in men [2].

The hormone serves two primary roles. First, it prepares the endometrial lining for embryo implantation by triggering secretory changes in the uterine glands [3]. Second, it maintains early pregnancy until the placenta takes over production around weeks 8 to 10 of gestation. Without adequate progesterone during this window, the endometrium sheds and pregnancy cannot be sustained.

Beyond reproduction, progesterone influences thermoregulation (causing the post-ovulatory basal body temperature rise of 0.3 to 0.5°C), modulates GABA-A receptor activity in the brain through its metabolite allopregnanolone, and plays a role in bone mineral density maintenance [4]. The Endocrine Society's 2017 clinical practice guideline on female infertility identifies mid-luteal progesterone as a first-line test for confirming ovulatory function [5]. In men, serum progesterone above 1.4 ng/mL may warrant investigation for adrenal pathology or congenital adrenal hyperplasia (CAH) [2].

What the Serum Progesterone Test Actually Measures

The standard serum progesterone test quantifies total circulating progesterone using immunoassay (most commonly chemiluminescent immunoassay, or CLIA) or liquid chromatography-tandem mass spectrometry (LC-MS/MS). LC-MS/MS is considered the reference method because it avoids cross-reactivity with structurally similar steroids like 17-hydroxyprogesterone [6].

This distinction matters clinically. Immunoassays can overestimate progesterone by 10 to 20% in certain contexts, particularly in women taking oral micronized progesterone, because the assay may detect inactive metabolites alongside active progesterone [6]. The Endocrine Society recommends that clinicians confirm which assay platform their lab uses before interpreting borderline results [5].

A single blood draw captures a snapshot. Progesterone is secreted in a pulsatile fashion during the luteal phase, with individual measurements varying by as much as 8 ng/mL over a few hours on the same day [7]. That pulsatility is why some reproductive endocrinologists prefer serial measurements or pooled samples rather than a single mid-luteal value. One reading of 4 ng/mL does not automatically indicate luteal insufficiency if the sample was drawn during a trough between secretory pulses.

Normal Progesterone Ranges by Phase and Population

Reference ranges for progesterone shift dramatically depending on the phase of the menstrual cycle, pregnancy status, sex, and menopausal status. A value that is normal in the follicular phase would signal a problem in the luteal phase, and vice versa.

Premenopausal women (non-pregnant):

During the follicular phase (days 1 through 14 of a typical 28-day cycle), progesterone stays low at 0.1 to 0.7 ng/mL [8]. After ovulation, the corpus luteum ramps production rapidly. Mid-luteal progesterone (days 19 to 23) typically falls between 5 and 25 ng/mL, with values above 10 ng/mL associated with optimal endometrial receptivity [3]. By day 28, if no pregnancy has occurred, the corpus luteum degenerates and levels fall below 1 ng/mL, triggering menstruation.

Pregnancy:

First-trimester values range from 11.2 to 90.0 ng/mL. By the third trimester, progesterone can reach 48.4 to 422.5 ng/mL as the placenta becomes the dominant source [9]. A single progesterone measurement below 5 ng/mL in early pregnancy is associated with a non-viable pregnancy in over 85% of cases, according to a 2020 analysis published in Fertility and Sterility [10].

Postmenopausal women:

Without ovarian cycling, progesterone drops to 0.0 to 0.4 ng/mL [8]. Values above this range in postmenopausal women not on HRT may indicate adrenal overproduction or, rarely, an ovarian tumor.

Men:

The normal range is 0.2 to 1.4 ng/mL. Progesterone in men serves as a precursor molecule in the steroidogenic pathway, converting to cortisol and testosterone [2].

What High Progesterone Means

Elevated progesterone outside of expected luteal or pregnancy ranges points to a short list of clinical possibilities. The context (cycle timing, pregnancy status, medication use) determines whether the elevation is physiologic or pathologic.

Ovulation is the most common explanation. A mid-luteal progesterone above 3 ng/mL simply confirms that the follicle ruptured and the corpus luteum formed [5]. Values between 10 and 25 ng/mL during the luteal phase are considered strong and suggest normal corpus luteum function.

Pregnancy produces the highest physiologic progesterone levels. Rising values that double appropriately in early gestation generally reflect a viable intrauterine pregnancy.

Pathologic causes of high progesterone include congenital adrenal hyperplasia (specifically 21-hydroxylase deficiency, where the progesterone-to-cortisol conversion is impaired), adrenal tumors, and certain ovarian tumors [11]. In women undergoing IVF, high progesterone on the day of trigger (above 1.5 ng/mL) has been associated with lower implantation rates in fresh transfer cycles, a finding confirmed in a meta-analysis of 60,000+ cycles published in Human Reproduction Update [12].

Exogenous progesterone from HRT, fertility treatments (vaginal inserts, intramuscular injections), or over-the-counter progesterone creams will also raise serum levels. Oral micronized progesterone (Prometrium) at the standard HRT dose of 200 mg nightly produces peak serum levels of approximately 17 to 28 ng/mL within 2 to 4 hours, dropping to 3 to 8 ng/mL by morning trough [13]. Timing the blood draw relative to the last dose is critical for accurate interpretation.

What Low Progesterone Means

Low progesterone is clinically significant in two main scenarios: anovulation and luteal phase deficiency (LPD). These overlap but are not identical.

Anovulation means the ovary did not release an egg. Without a corpus luteum, progesterone stays at follicular-phase levels (below 1 ng/mL) throughout the entire cycle. Common causes include polycystic ovary syndrome (PCOS), hypothalamic amenorrhea from caloric restriction or excessive exercise, hyperprolactinemia, and thyroid dysfunction [5]. PCOS alone accounts for 80% of anovulatory infertility, according to the American College of Obstetricians and Gynecologists (ACOG) [14].

Luteal phase deficiency occurs when the corpus luteum produces insufficient progesterone (typically 3 to 5 ng/mL mid-luteal) or degenerates prematurely, resulting in a luteal phase shorter than 10 days. The American Society for Reproductive Medicine (ASRM) notes that LPD remains a controversial diagnosis because no single diagnostic threshold has been universally validated, though mid-luteal progesterone below 10 ng/mL combined with a short luteal phase and recurrent pregnancy loss raises clinical concern [15].

Low progesterone in early pregnancy (below 5 ng/mL) correlates with ectopic pregnancy or impending miscarriage. A 2021 Cochrane review of 10 trials (N=4,853) found that vaginal progesterone supplementation reduced miscarriage rates in women with early pregnancy bleeding and a history of recurrent loss (RR 0.73, 95% CI 0.54 to 1.00) [16].

In men, progesterone below the reference range is rarely tested for or clinically acted upon, though emerging research suggests it may correlate with reduced sperm motility [2].

How Clinicians Use Progesterone in HRT Monitoring

For women on combined estrogen-progesterone HRT, progesterone testing serves two purposes: confirming endometrial protection and optimizing symptom control.

Unopposed estrogen therapy increases the risk of endometrial hyperplasia and cancer. Adding progesterone for at least 12 to 14 days per cycle (in sequential regimens) or continuously counteracts estrogen's proliferative effect on the endometrium [17]. The North American Menopause Society (NAMS) 2022 position statement recommends progestogen co-therapy for all women with a uterus who take systemic estrogen [18].

Serum progesterone monitoring is especially relevant for women using non-oral routes, such as vaginal or transdermal progesterone, where absorption varies widely between individuals. A mid-treatment trough level below 5 ng/mL on vaginal micronized progesterone may indicate inadequate endometrial protection, though endometrial biopsy remains the gold standard for confirming secretory transformation [13].

For women on bioidentical progesterone compounded as sublingual troches or topical creams, serum testing may not accurately reflect tissue-level exposure. The Endocrine Society and NAMS both caution that salivary progesterone testing, frequently marketed by compounding pharmacies, lacks standardization and should not guide clinical decisions [18].

In transgender men receiving testosterone therapy, baseline progesterone is occasionally checked before oophorectomy. Persistent progesterone above follicular-phase levels after several months of testosterone may suggest incomplete ovarian suppression [19].

How to Raise Low Progesterone

Raising progesterone levels depends on the underlying cause. The approach differs between women trying to conceive, women on HRT, and individuals addressing non-reproductive symptoms.

Ovulation induction is the first step for anovulatory women. Letrozole 2.5 to 7.5 mg on cycle days 3 through 7 is now preferred over clomiphene as first-line ovulation induction for PCOS, based on the NICHD Reproductive Medicine Network trial (N=750), which showed higher live birth rates with letrozole (27.5% vs. 19.1%, P=0.007) [20]. Successful ovulation restores endogenous progesterone production.

Progesterone supplementation is used directly in luteal phase support and HRT. Options include vaginal micronized progesterone (Endometrin 100 mg twice daily or Crinone 8% gel), oral micronized progesterone (Prometrium 200 to 300 mg nightly), and intramuscular progesterone in oil (50 to 100 mg daily, commonly used in IVF cycles) [15]. Each route has a different pharmacokinetic profile. Vaginal progesterone achieves high endometrial concentrations with lower serum levels (the "uterine first-pass effect"), meaning that a serum level of 3 ng/mL on vaginal progesterone may still reflect adequate endometrial exposure [21].

Lifestyle factors play a supporting role. Chronic stress activates the hypothalamic-pituitary-adrenal axis and can divert pregnenolone toward cortisol synthesis at the expense of progesterone (sometimes called "pregnenolone steal," though this concept is debated in endocrine literature) [4]. Adequate caloric intake is non-negotiable for ovulatory function. Female athletes with relative energy deficiency in sport (RED-S) frequently present with anovulation and low progesterone, and caloric restoration alone often restores cycles within 3 to 6 months [22].

How to Lower Progesterone

Clinically, lowering endogenous progesterone is rarely a therapeutic goal. The scenarios where it applies are specific.

In IVF cycles, premature progesterone rise (above 1.5 ng/mL before trigger) is managed by freezing all embryos and transferring in a subsequent cycle rather than attempting to suppress progesterone itself [12]. Some protocols use GnRH antagonists (cetrorelix, ganirelix) during stimulation to prevent premature luteinization, which indirectly keeps progesterone low until the intended trigger day [23].

In congenital adrenal hyperplasia, elevated progesterone is a downstream consequence of impaired cortisol synthesis. Treatment with glucocorticoids (hydrocortisone 10 to 15 mg/m² daily in adults) suppresses ACTH, which in turn reduces adrenal progesterone overproduction [11].

For women experiencing side effects from exogenous progesterone on HRT (drowsiness, bloating, mood changes), dose reduction or route change, for example switching from oral to vaginal, often resolves symptoms while maintaining endometrial protection [18]. The drowsiness associated with oral progesterone is mediated by its metabolite allopregnanolone, which acts as a positive allosteric modulator of GABA-A receptors. Taking the dose at bedtime turns this side effect into a therapeutic benefit for sleep [4].

There is no evidence that dietary changes or supplements meaningfully lower endogenous progesterone production in healthy cycling women. Claims about specific foods "reducing progesterone" lack clinical trial support.

When to Order a Progesterone Test

The timing of the blood draw determines whether the result is interpretable. A progesterone level drawn on cycle day 7 cannot confirm or rule out ovulation because the corpus luteum has not yet had time to produce meaningful amounts.

To confirm ovulation: Draw mid-luteal, approximately 7 days before the expected period. For a 28-day cycle, this is day 21. For a 35-day cycle, day 28. The "day 21 progesterone" label is misleading for women with longer or irregular cycles [5].

To evaluate early pregnancy viability: A single draw at the time of presentation, typically between 5 and 8 weeks. Values above 25 ng/mL are strongly associated with viable intrauterine pregnancy. Values below 5 ng/mL suggest non-viability [10].

To monitor HRT: Draw a trough level, meaning just before the next scheduled dose. For oral progesterone taken at bedtime, the morning value reflects trough. For vaginal progesterone, timing varies by formulation, and the ordering clinician should specify.

To evaluate amenorrhea: A random progesterone level in the context of amenorrhea helps distinguish between anovulation (low) and the luteal phase of an unrecognized cycle (elevated). Pair with FSH, LH, estradiol, TSH, and prolactin for a complete workup [5].

No fasting is required. Lipemia from a recent high-fat meal does not interfere with most progesterone assays [6].

Progesterone vs. 17-Hydroxyprogesterone: Two Different Tests

These are frequently confused. They measure different molecules with different clinical applications.

Progesterone (P4) is the active hormone. 17-hydroxyprogesterone (17-OHP) is a precursor in the cortisol synthesis pathway, and its primary clinical use is screening for and monitoring congenital adrenal hyperplasia [11]. In 21-hydroxylase deficiency (the most common form of CAH, accounting for 90 to 95% of cases), 17-OHP accumulates because the enzyme that converts it to 11-deoxycortisol is deficient or absent.

Ordering "progesterone" when you need a CAH screen, or ordering "17-OHP" when you need ovulation confirmation, yields results that cannot answer the clinical question. Both tests use the same sample (serum from a standard blood draw), but they are separate assays with separate reference ranges. If the clinical question involves adrenal function or CAH, order 17-OHP. If the question involves ovulation, pregnancy, or HRT monitoring, order progesterone.

A baseline 17-OHP above 200 ng/dL (6 nmol/L) in the early morning follicular phase warrants ACTH stimulation testing to evaluate for non-classic CAH, per Endocrine Society guidelines [11]. This threshold does not apply to progesterone.